{"url":"https://lda.senate.gov/api/v1/filings/f700d563-e458-47a7-8be5-afb7974e9bf6/","filing_uuid":"f700d563-e458-47a7-8be5-afb7974e9bf6","filing_type":"RR","filing_type_display":"Registration","filing_year":2020,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f700d563-e458-47a7-8be5-afb7974e9bf6/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Shane Vicry","dt_posted":"2020-07-30T15:04:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"615 U Street, NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401105372,"url":"https://lda.senate.gov/api/v1/registrants/401105372/","house_registrant_id":null,"name":"THE KPM GROUP DC LLC","description":"lobby firm","address_1":"5331 16th Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20011","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISA HESS","contact_telephone":"+1 434-933-2535","dt_updated":"2026-07-20T15:33:02.088040-04:00"},"client":{"id":206463,"url":"https://lda.senate.gov/api/v1/clients/206463/","client_id":75,"name":"AEGLEA BIOTHERAPEUTICS, INC.","general_description":"Clinical-stage biotechnology company; designs and develops human enzyme therapeutics","client_government_entity":false,"client_self_select":null,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-05-15"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Priority Review Vouchers and Biomedical Advanced Research and Development Authority (BARDA) engagement","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":72652,"prefix":null,"prefix_display":null,"first_name":"PATROSKI","nickname":null,"middle_name":null,"last_name":"LAWSON","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":73276,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":"Communications Director; Rep. David Young  January 2017 - June 2017","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}